Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

2022
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-29T18:38:40
publisher: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.
label: RDF description of Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism. - http://research.umh.es/vivo/pub/articulo/248640

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.
type: Entity
has publication venue: INTERNAL AND EMERGENCY MEDICINE
related by: Autor:128504-Artículo:248640
type: Continuant
page start: 725
page end: 734
type: Information Content Entity
type: 2022
ARG_2000028: 248640 vcard
most specific type: Academic Article
type: Document
type: Thing
type: Academic Article
date time value: 248640 pubdate
included: Medicina Clínica 2022
most specific type: 2022
type: Generically Dependent Continuant
type: Anualidad
type: Article

INTERNAL AND EMERGENCY MEDICINE
type: Collection
type: Journal
type: Generically Dependent Continuant
type: Periodical
type: Entity
publication venue for: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.
type: Thing
type: Information Content Entity
type: Continuant

Autor:128504-Artículo:248640
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.

Medicina Clínica 2022
type: 2022
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
includes: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.